What Vyepti is, who it's for, and what an infusion day actually looks like. Written for patients and caregivers in Maryland.
Vyepti (eptinezumab-jjmr) is an infused medication that prevents migraine. It blocks a protein called CGRP that carries pain signaling during an attack. The standard dose is one infusion every three months, and the medication itself runs for about 30 minutes. There is no starting series and no loading dose, so your first appointment looks like every appointment after it. Springside administers Vyepti in Columbia, Bowie, and Frederick, Maryland. Your prescriber keeps managing your migraine. We handle the infusion, the insurance authorization, and the paperwork.
Vyepti is the brand name for eptinezumab-jjmr, a medication given by IV infusion to prevent migraine.
It is a monoclonal antibody, a lab-made protein built to attach to one specific target in the body. Vyepti's target is CGRP, short for calcitonin gene-related peptide.
The distinction that matters most on the day you start: Vyepti is a preventive treatment. It is not something you take when an attack begins, and it will not shorten a migraine you already have. Whatever you use to treat an attack in the moment stays in the picture unless your prescriber says otherwise.
CGRP is a small protein released around the nerves and blood vessels of the head. Levels of it rise during a migraine attack, and it plays a part in widening blood vessels and passing along the pain signaling that makes an attack feel the way it does.
Vyepti binds to CGRP so it cannot reach its receptor. Less of that signaling gets through.
It does not cure migraine and it does not repair whatever makes your nervous system prone to attacks. The goal is fewer migraine days over time, measured across months rather than judged from one week.
Vyepti is FDA-approved for the preventive treatment of migraine in adults.
Prescribers usually reach for a preventive when attacks are frequent enough to take real days away from you, or when the preventives you have already tried did not help or came with side effects you could not live with. How many attacks you get, what you have taken before, and what else you are being treated for all feed into that decision.
Tell your prescriber if you have high blood pressure, a history of Raynaud's phenomenon, or ongoing trouble with constipation. Those come up again in the monitoring section below, and they are worth raising before your first dose rather than after it.
Your prescriber decides whether Vyepti is appropriate. This page explains what the treatment involves once they have.
Vyepti runs on a simple rhythm. One infusion every three months, four visits a year.
The recommended dose is 100 mg given by IV infusion every three months. Some patients may benefit from 300 mg every three months instead. That is a decision your prescriber makes, and it comes through on the referral.
There is no build-up phase. Unlike some infused medications, Vyepti has no half doses at the start and no series of closely spaced first appointments. Your first infusion is the same dose, on the same clock, as the ones that follow.
Exact doses and timings come from your prescriber. The schedule above is the standard pattern, not a substitute for the plan they write.
Each links to its condition guide, where you’ll find the other infusion medications used to treat it.
This is one of the shorter infusion appointments we run. Here is the shape of a typical visit.
Plan for longer than 30 minutes. That number is the medication running, and check-in, preparation, and IV placement sit on top of it. When we confirm your appointment, we'll tell you how long to plan for. Most people drive themselves and go back to their day afterward.
In the trials that supported approval, the reactions reported most often were cold and stuffy-nose symptoms and allergic-type reactions.
Hypersensitivity reactions have happened during Vyepti infusions. That can look like hives, flushing in the face, a rash, swelling under the skin, or shortness of breath. If one happens, we stop the infusion and treat it. This is planned for rather than treated as a surprise, and it is one of the reasons a nurse stays with you.
Tell us right away if your face, lips, or throat feel tight or swollen, if you break out in hives, or if breathing gets harder. Do not wait to see whether it passes.
Three things on the label are worth knowing by name, because they show up in the weeks between appointments rather than in the chair.
Tell us at check-in if you had a reaction to a previous infusion, feel unwell that day, or have started a new medication since your last visit.
You can change where you receive your Vyepti infusions without changing your prescriber. Your neurologist or headache specialist continues to manage your migraine and writes the order. We administer the infusion and report back to them.
Many Maryland insurance plans now prefer, and some require, that non-urgent infusions be given at an ambulatory infusion center rather than a hospital outpatient department, often at meaningfully lower out-of-pocket cost. Coverage rules and prior-authorization requirements vary by plan, so we verify your benefits and handle the authorization before your first visit.
Please include the following with your referral:
